Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Comparing 2 Dividend Plays In Healthcare
Seeking Alpha
Wednesday, May 23, 2012 - 11:45am
tags:
dividends, Pfizer, JNJ
Novo’s Insulin Pill Quest Is Holy Grail For Diabetics
Bloomberg
Wednesday, May 23, 2012 - 11:45am
tags:
insulin, diabetes, Novo Nordisk
Biotechs raise new VC rounds to back inhalable drugs, antimicrobials
Fierce Biotech
Tuesday, May 22, 2012 - 11:28am
tags:
Zurex Pharma, venture capital, Prosonix
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tuesday, May 22, 2012 - 11:25am
tags:
Ziopharm, Zalicus, EXACT Sciences, Geron, Lexicon Pharmaceuticals, Nektar, Vical, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Eli Lilly, JNJ, Pfizer, Elan, Biomarin, Biogen Idec, Auxilium, Arqule, Anthera, Acadia, Amicus Therapeutics, Vertex Pharmaceuticals
Merck CEO: Generics, economy to make 2012-13 tough
Yahoo/AP
Tuesday, May 22, 2012 - 11:19am
tags:
Merck, generics, Kenneth Frazier, Pharma CEOs
FDA staff shoots down Pfizer rare disease drug
Yahoo/Reuters
Tuesday, May 22, 2012 - 11:19am
tags:
FDA, Pfizer, Vyndaqel, familial amyloid polyneuropathy
Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tuesday, May 22, 2012 - 11:16am
tags:
Medivation, Astellas, prostate cancer, Enzalutamide
Sales Rep Bans Are A Doubled-Edged Sword?
Pharmalot
Tuesday, May 22, 2012 - 10:03am
tags:
drug reps, physician access
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Tuesday, May 22, 2012 - 9:42am
tags:
Bayer, Onyx, Nexavar, lung cancer
InterMune to Sell Actimmune Rights
Yahoo/Zacks.com
Tuesday, May 22, 2012 - 9:40am
tags:
InterMune, Actimmune, Vidara, osteoporosis
Stem Cell Hype Has Yet To Breed Profits
Seeking Alpha
Tuesday, May 22, 2012 - 9:03am
tags:
stem cells, Geron, StemCells, Osiris, BioTime, Advanced Cell Technology
Brief Review Of A Few Biotechs
Seeking Alpha
Tuesday, May 22, 2012 - 8:58am
tags:
Amarin, Abbott Laboratories, Arena Pharmaceuticals, Osiris
Ampio Pharmaceuticals Is Positioned For A Rebound
Seeking Alpha
Tuesday, May 22, 2012 - 8:55am
tags:
Ampio Pharmaceuticals
Meda Cash Flow Invites Pipeline Deal At 95% Discount
Bloomberg
Tuesday, May 22, 2012 - 8:54am
tags:
Meda
Achillion jumps on hepatitis C study
Marketwatch
Monday, May 21, 2012 - 4:49pm
tags:
Achillion, hepatitis C, ACH-2684
5 Reasons To Buy Navidea Biopharmaceuticals
Seeking Alpha
Monday, May 21, 2012 - 4:37pm
tags:
Navidea Biopharmaceuticals, AstraZeneca
Teva's New CEO: A Positive Catalyst Going Forward
Seeking Alpha
Monday, May 21, 2012 - 4:36pm
tags:
Teva Pharmaceuticals, Pharma CEOs, Novartis, Bristol-Myers Squibb
Erectile Dysfunction: Vivus' Stendra Can't Stop Cialis
Motley Fool
Monday, May 21, 2012 - 4:20pm
tags:
erectile dysfunction, Vivus, Stendra, Cialis, Eli Lilly
Contract sales sector “shrunk” in 2011, PDI CEO says
Outsourcing Pharma
Monday, May 21, 2012 - 12:57pm
tags:
contract sales, PDI, Nancy Lurker
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
Xconomy
Monday, May 21, 2012 - 12:55pm
tags:
Regeneron, Illumina, Vivus, Seattle Genetics, Cubist Pharmaceuticals, Onyx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.